Stoner Kelly L, Harder Helena, Fallowfield Lesley J, Jenkins Valerie A
Sussex Health Outcomes Research and Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, Science Park Road, Falmer, Brighton, BN1 9RX, UK.
Patient. 2014 Jul 12. doi: 10.1007/s40271-014-0075-y.
Intravenous (IV) drug delivery is commonly used for its rapid administration and immediate drug effect. Most studies compare IV to subcutaneous (SC) delivery in terms of safety and efficacy, but little is known about what patients prefer.
A systematic review was conducted by searching seven electronic databases for articles published up to February 2014. Included studies were randomized controlled trials (RCTs) and/or crossover designs investigating patient preference for SC versus IV administration. The risk of bias in the RCTs was determined using the Cochrane Collaboration tool. Reviewers independently extracted data and assessed the risk of bias. Any discrepancies were resolved by consensus.
The search identified 115 publications, but few (6/115) met the inclusion criteria. Patient populations and drugs investigated were diverse. Four of six studies demonstrated a clear patient preference for SC administration. Main factors associated with SC preference were time saving and the ability to have treatment at home. Only three studies used study-specific instruments to measure preference.
Results suggest that patients prefer SC over IV delivery. Patient preference has clearly been neglected in clinical research, but it is important in medical decision making when choosing treatment methods as it has implications for adherence and quality of life. If the safety and efficacy of both administration routes are equivalent, then the most important factor should be patient preference as this will ensure optimal treatment adherence and ultimately improve patient experience or satisfaction. Future drug efficacy and safety studies should include contemporaneous, actual patient preference where possible, utilizing appropriate measures.
静脉注射给药因其给药迅速且能立即产生药物效果而被广泛使用。大多数研究在安全性和有效性方面将静脉注射与皮下注射进行比较,但对于患者的偏好了解甚少。
通过检索七个电子数据库,对截至2014年2月发表的文章进行系统综述。纳入的研究为随机对照试验(RCT)和/或交叉设计,旨在调查患者对皮下注射与静脉注射给药的偏好。使用Cochrane协作工具确定RCT中的偏倚风险。评审人员独立提取数据并评估偏倚风险。任何差异均通过协商解决。
检索到115篇出版物,但很少有(6/115)符合纳入标准。所研究的患者群体和药物各不相同。六项研究中有四项表明患者明显偏好皮下注射给药。与皮下注射偏好相关的主要因素是节省时间和能够在家中接受治疗。只有三项研究使用特定研究的工具来测量偏好。
结果表明患者更喜欢皮下注射而非静脉注射给药。患者偏好显然在临床研究中被忽视了,但在选择治疗方法时的医疗决策中很重要,因为它对依从性和生活质量有影响。如果两种给药途径的安全性和有效性相当,那么最重要的因素应该是患者偏好,因为这将确保最佳的治疗依从性,并最终改善患者体验或满意度。未来的药物疗效和安全性研究应尽可能纳入同期的实际患者偏好,并采用适当的测量方法。